Patents by Inventor Chung-Kang Peng
Chung-Kang Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10354422Abstract: The present invention provides a diagram building system adapted for processing a signal with a time period. The diagram building system comprises a inputting device for receiving the signal; a computing device, dividing the signal into a plurality of window scales according to one of time interval scales; decomposing the window scales via HHT algorithm to generate a plurality of quantized windows according to different components; then, calculating the value of quantized windows with the same single-frequency component through a quantifying function to generate a plurality of specific frequency values; an outputting device, sequentially arranging the specific frequency values according to the time interval scales and the single-frequency components to form a visual diagram.Type: GrantFiled: April 4, 2016Date of Patent: July 16, 2019Assignee: NATIONAL CENTRAL UNIVERSITYInventors: Norden E. Huang, Bo-Jau Kuo, Yu-Cheng Lin, Chung-Kang Peng, Men-Tzung Lo
-
Publication number: 20160292894Abstract: The present invention provides a diagram building system adapted for processing a signal with a time period. The diagram building system comprises a inputting device for receiving the signal; a computing device, dividing the signal into a plurality of window scales according to one of time interval scales; decomposing the window scales via HHT algorithm to generate a plurality of quantized windows according to different components; then, calculating the value of quantized windows with the same single-frequency component through a quantifying function to generate a plurality of specific frequency values; an outputting device, sequentially arranging the specific frequency values according to the time interval scales and the single-frequency components to form a visual diagram.Type: ApplicationFiled: April 4, 2016Publication date: October 6, 2016Inventors: Norden. E. HUANG, Bo-Jau KUO, Yu-Cheng LIN, Chung-Kang PENG, Men-Tzung LO
-
Publication number: 20150193376Abstract: This invention discloses a multi-scales intrinsic entropy analysis method that can quantify the entropies on difference time scales for a complex time series. The implementation of the method decomposes a complex time series into a plurality of intrinsic mode functions by a nonlinear signal processing algorithm, such as the method of empirical mode decomposition. Then, the entropy increments can be calculated on multiple coarse-graining scales when an intrinsic mode functions is added into the reconstructed time series analyzed by the method of multi-scale entropy. The entropy increment is significant on a specific coarse-graining scale, which corresponds to the averaged period of the intrinsic mode functions. The entropy increment on the specific coarse-graining scale is defined as the intrinsic entropy for an intrinsic mode functions. Multiple intrinsic entropies represent the entropy properties for a complex time series on their corresponding time scales.Type: ApplicationFiled: April 4, 2014Publication date: July 9, 2015Applicant: National Central UniversityInventors: Jia-Rong YEH, Norden E. HUANG, Men-Tzung LO, Chung-Kang PENG
-
Publication number: 20150162009Abstract: The present invention provides an analysis system adapted for processing a signal with a time period. The analysis system comprises a segmenting unit, an analyzing unit, processing unit and an outputting unit. The segmenting unit divides the signal into a plurality of scale windows according to one of interval scales. The analyzing unit processes the scale windows via HHT algorithm to make each scale window generate a plurality of quantized windows according to different components. The processing unit reorganizes the quantized windows make each scale window generate a plurality of quantized windows according to different components. The outputting unit accumulates a plurality of specific frequency values in difference interval scales and combines the specific frequency values to form a three-dimensional variation visual diagram.Type: ApplicationFiled: May 8, 2014Publication date: June 11, 2015Applicant: National Central UniversityInventors: Norden. E. Huang, Bo-Jau Kuo, Yu-Cheng Lin, Chung-Kang Peng, Men-Tzung Lo
-
Patent number: 8403848Abstract: An assessment of sleep quality and sleep disordered breathing is determined from the cardiopulmonary coupling between two physiological data series. In an embodiment, an R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal (NN) interval series. The amplitude variations in the QRS complex are used to extract to a surrogate respiration signal (i.e., ECG-derived respiration (EDR)) that is associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross power. Using the appropriate thresholds for the coherent cross power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: GrantFiled: January 23, 2008Date of Patent: March 26, 2013Assignee: Beth Israel Deaconess Medical Center, Inc.Inventors: Joseph E. Mietus, Chung-Kang Peng, Robert Joseph Thomas, Ary L. Goldberger
-
Patent number: 8401626Abstract: An assessment of sleep quality and sleep disordered breathing is determined from cardiopulmonary coupling between two physiological data series. An R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal interval series. The amplitude variations in the QRS complex are used to extract a surrogate respiration signal (i.e., ECG-derived respiration) associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross-power. Using the appropriate thresholds for the coherent cross-power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: GrantFiled: September 30, 2009Date of Patent: March 19, 2013Assignee: Beth Israel Deaconess Medical Center, Inc.Inventors: Joseph E. Mietus, Chung-Kang Peng, Robert Joseph Thomas, Ary L. Goldberger
-
Patent number: 7882167Abstract: In a subject undergoing therapeutic intervention, efficacy of the therapeutic intervention is assessed based on a series of physiologic data associated with the subject. The series of physiologic data is analyzed to produce a measure of complexity. The complexity measure is then compared to a control. The efficacy of the therapeutic intervention is assessed based on the comparison of the complexity measure to the control. The control may be, for example, a complexity measure taken prior to initiation of the therapeutic intervention, a complexity measure taken from a different subject, or a predetermined threshold value. The measure of complexity is generated using, for example, a multiscale entropy measurement (MSE), a time asymmetry measurement, and/or an information-based similarity measurement. An increase in complexity indicates a positive effect of the therapeutic intervention, while a decrease in complexity indicates a negative effect of the therapeutic intervention.Type: GrantFiled: July 10, 2006Date of Patent: February 1, 2011Assignee: Beth Israel Deaconess Medical CenterInventors: Ary L. Goldberger, Chung-Kang Peng, Madalena D. Costa
-
Patent number: 7734334Abstract: An assessment of sleep quality and sleep disordered breathing is determined from cardiopulmonary coupling between two physiological data series. An R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal interval series. The amplitude variations in the QRS complex are used to extract a surrogate respiration signal (i.e., ECG-derived respiration) associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross-power. Using the appropriate thresholds for the coherent cross-power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: GrantFiled: July 12, 2005Date of Patent: June 8, 2010Assignee: Beth Israel Deaconess Medical Center, Inc.Inventors: Joseph E. Mietus, Chung-Kang Peng, Robert J. Thomas, Ary L. Goldberger
-
Publication number: 20100069762Abstract: An assessment of sleep quality and sleep disordered breathing is determined from cardiopulmonary coupling between two physiological data series. An R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal interval series. The amplitude variations in the QRS complex are used to extract a surrogate respiration signal (i.e., ECG-derived respiration) associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross-power. Using the appropriate thresholds for the coherent cross-power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: ApplicationFiled: September 30, 2009Publication date: March 18, 2010Applicant: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.Inventors: Joseph E. Mietus, Chung-Kang Peng, Robert J. Thomas, Ary L. Goldberger
-
Publication number: 20090316976Abstract: Provided herein are methods and systems for assessing cellular flickering. The methods include using a phase contrast microscope to obtain a plurality of images of a cell, digitizing and/or pixilating the plurality of images such that the plurality of images are segmented into an array of pixels, each pixel representing a portion of the cell, and measuring the fluctuations in the pixel intensities. The methods further include calculating a complexity measure for the individual pixels based on the measured fluctuations of the portions of the cell represented by the individual pixels. Such complexity measures can then be mapped and/or plotted in order to assess cellular flickering, and thereby assess biological function and other characteristics of the cell.Type: ApplicationFiled: June 12, 2009Publication date: December 24, 2009Inventors: Madalena Damasio Costa, Ionita Ghiran, Chung-Kang Peng, Anne Nicholson-Weller, Ary L. Goldberger
-
Patent number: 7601124Abstract: In a subject undergoing therapeutic intervention, efficacy of the therapeutic intervention is assessed based on a series of physiologic data associated with the subject. The series of physiologic data is analyzed to produce a measure of complexity. The complexity measure is then compared to a control. The efficacy of the therapeutic intervention is assessed based on the comparison of the complexity measure to the control. The control may be, for example, a complexity measure taken prior to initiation of the therapeutic intervention, a complexity measure taken from a different subject, or a predetermined threshold value. The measure of complexity is generated using, for example, a multiscale entropy measurement (MSE), a time asymmetry measurement, and/or an information-based similarity measurement. An increase in complexity indicates a positive effect of the therapeutic intervention, while a decrease in complexity indicates a negative effect of the therapeutic intervention.Type: GrantFiled: February 17, 2006Date of Patent: October 13, 2009Assignee: Beth Israel Deaconess Medical CenterInventors: Ary L. Goldberger, Chung-Kang Peng, Madalena D. Costa
-
Publication number: 20080119747Abstract: An assessment of sleep quality and sleep disordered breathing is determined from the cardiopulmonary coupling between two physiological data series. In an embodiment, an R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal (NN) interval series. The amplitude variations in the QRS complex are used to extract to a surrogate respiration signal (i.e., ECG-derived respiration (EDR)) that is associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross power. Using the appropriate thresholds for the coherent cross power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: ApplicationFiled: January 23, 2008Publication date: May 22, 2008Applicant: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.Inventors: Joseph MIETUS, Chung-Kang Peng, Robert Thomas, Ary Goldberger
-
Patent number: 7324845Abstract: An assessment of sleep quality and sleep disordered breathing is determined from the cardiopulmonary coupling between two physiological data series. In an embodiment, an R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal (NN) interval series. The amplitude variations in the QRS complex are used to extract to a surrogate respiration signal (i.e., ECG-derived respiration (EDR)) that is associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross power. Using the appropriate thresholds for the coherent cross power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: GrantFiled: May 17, 2004Date of Patent: January 29, 2008Assignee: Beth Israel Deaconess Medical CenterInventors: Joseph E. Mietus, Chung-Kang Peng, Robert J. Thomas, Ary L. Goldberger
-
Publication number: 20070066906Abstract: In a subject undergoing therapeutic intervention, efficacy of the therapeutic intervention is assessed based on a series of physiologic data associated with the subject. The series of physiologic data is analyzed to produce a measure of complexity. The complexity measure is then compared to a control. The efficacy of the therapeutic intervention is assessed based on the comparison of the complexity measure to the control. The control may be, for example, a complexity measure taken prior to initiation of the therapeutic intervention, a complexity measure taken from a different subject, or a predetermined threshold value. The measure of complexity is generated using, for example, a multiscale entropy measurement (MSE), a time asymmetry measurement, and/or an information-based similarity measurement. An increase in complexity indicates a positive effect of the therapeutic intervention, while a decrease in complexity indicates a negative effect of the therapeutic intervention.Type: ApplicationFiled: July 10, 2006Publication date: March 22, 2007Applicant: Beth Israel Deaconess Medical CenterInventors: Ary Goldberger, Chung-Kang Peng, Madalena Costa
-
Publication number: 20060189875Abstract: In a subject undergoing therapeutic intervention, efficacy of the therapeutic intervention is assessed based on a series of physiologic data associated with the subject. The series of physiologic data is analyzed to produce a measure of complexity. The complexity measure is then compared to a control. The efficacy of the therapeutic intervention is assessed based on the comparison of the complexity measure to the control. The control may be, for example, a complexity measure taken prior to initiation of the therapeutic intervention, a complexity measure taken from a different subject, or a predetermined threshold value. The measure of complexity is generated using, for example, a multiscale entropy measurement (MSE), a time asymmetry measurement, and/or an information-based similarity measurement. An increase in complexity indicates a positive effect of the therapeutic intervention, while a decrease in complexity indicates a negative effect of the therapeutic intervention.Type: ApplicationFiled: February 17, 2006Publication date: August 24, 2006Applicant: Beth Israel Deaconess Medical CenterInventors: Ary Goldberger, Chung-Kang Peng, Madalena Costa
-
Publication number: 20050267362Abstract: An assessment of sleep quality and sleep disordered breathing is determined from cardiopulmonary coupling between two physiological data series. An R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal interval series. The amplitude variations in the QRS complex are used to extract a surrogate respiration signal (i.e., ECG-derived respiration) associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross-power. Using the appropriate thresholds for the coherent cross-power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: ApplicationFiled: July 12, 2005Publication date: December 1, 2005Applicant: Beth Israel Deaconess Medical CenterInventors: Joseph Mietus, Chung-Kang Peng, Robert Thomas, Ary Goldberger
-
Publication number: 20050256418Abstract: An assessment of sleep quality and sleep disordered breathing is determined from the cardiopulmonary coupling between two physiological data series. In an embodiment, an R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal (NN) interval series. The amplitude variations in the QRS complex are used to extract to a surrogate respiration signal (i.e., ECG-derived respiration (EDR)) that is associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross power. Using the appropriate thresholds for the coherent cross power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.Type: ApplicationFiled: May 17, 2004Publication date: November 17, 2005Applicant: Beth Israel Deaconess Medical CenterInventors: Joseph Mietus, Chung-Kang Peng, Robert Thomas, Ary Goldberger